{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:00:49Z","timestamp":1791241249952,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:00Z","timestamp":1393372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00428-014-1549-y","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T10:16:08Z","timestamp":1393323368000},"page":"419-427","source":"Crossref","is-referenced-by-count":32,"title":["microRNA expression might predict prognosis of epithelial hepatoblastoma"],"prefix":"10.1007","volume":"464","author":[{"given":"M\u00f3nika","family":"Gyugos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Lendvai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Kenessey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Schlachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Hal\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Garami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsa","family":"Jakab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsa","family":"Schaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,26]]},"reference":[{"key":"1549_CR1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s12098-012-0704-1","volume":"79","author":"S Agarwala","year":"2012","unstructured":"Agarwala S (2012) Primary malignant liver tumors in children. Indian J Pediatr 79:793\u2013800","journal-title":"Indian J Pediatr"},{"key":"1549_CR2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/pbc.24214","volume":"59","author":"D Lopez-Terrada","year":"2012","unstructured":"Lopez-Terrada D, Zimmermann A (2012) Current issues and controversies in the classification of pediatric hepatocellular tumors. Pediatr Blood Cancer 59:780\u2013784","journal-title":"Pediatr Blood Cancer"},{"key":"1549_CR3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/hpb.12112","volume":"15","author":"BJ Allan","year":"2013","unstructured":"Allan BJ, Parikh PP, Diaz S, Perez EA, Neville HL, Sola JE (2013) Predictors of survival and incidence of hepatoblastoma in the paediatric population. HPB (Oxford) 15:741\u2013746","journal-title":"HPB (Oxford)"},{"key":"1549_CR4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1756-9966-30-96","volume":"30","author":"R Purcell","year":"2011","unstructured":"Purcell R, Childs M, Maibach R, Miles C, Turner C, Zimmermann A, Sullivan M (2011) HGF\/c-Met related activation of beta-catenin in hepatoblastoma. J Exp Clin Cancer Res 30:96","journal-title":"J Exp Clin Cancer Res"},{"key":"1549_CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00428-007-0571-8","volume":"452","author":"K Dezso","year":"2008","unstructured":"Dezso K, Halasz J, Bisgaard HC, Paku S, Turanyi E, Schaff Z, Nagy P (2008) Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas. Virchows Arch 452:443\u2013448","journal-title":"Virchows Arch"},{"key":"1549_CR6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.humpath.2005.12.015","volume":"37","author":"J Halasz","year":"2006","unstructured":"Halasz J, Holczbauer A, Paska C, Kovacs M, Benyo G, Verebely T, Schaff Z, Kiss A (2006) Claudin-1 and claudin-2 differentiate fetal and embryonal components in human hepatoblastoma. Hum Pathol 37:555\u2013561","journal-title":"Hum Pathol"},{"key":"1549_CR7","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.ejca.2011.10.019","volume":"48","author":"R Purcell","year":"2012","unstructured":"Purcell R, Childs M, Maibach R, Miles C, Turner C, Zimmermann A, Czauderna P, Sullivan M (2012) Potential biomarkers for hepatoblastoma: results from the SIOPEL-3 study. Eur J Cancer 48:1853\u20131859","journal-title":"Eur J Cancer"},{"key":"1549_CR8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<690::AID-CNCR9>3.0.CO;2-O","volume":"83","author":"A Kiss","year":"1998","unstructured":"Kiss A, Szepesi A, Lotz G, Nagy P, Schaff Z (1998) Expression of transforming growth factor-alpha in hepatoblastoma. Cancer 83:690\u2013697","journal-title":"Cancer"},{"key":"1549_CR9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.humpath.2008.10.022","volume":"40","author":"AM Adesina","year":"2009","unstructured":"Adesina AM, Lopez-Terrada D, Wong KK, Gunaratne P, Nguyen Y, Pulliam J, Margolin J, Finegold MJ (2009) Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways. Hum Pathol 40:843\u2013853","journal-title":"Hum Pathol"},{"key":"1549_CR10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2741\/e393","volume":"4","author":"S Cairo","year":"2012","unstructured":"Cairo S, Armengol C, Buendia MA (2012) Activation of Wnt and Myc signaling in hepatoblastoma. Front Biosci (Elite Ed) 4:480\u2013486","journal-title":"Front Biosci (Elite Ed)"},{"key":"1549_CR11","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00216-011-5001-8","volume":"401","author":"M Ciesla","year":"2011","unstructured":"Ciesla M, Skrzypek K, Kozakowska M, Loboda A, Jozkowicz A, Dulak J (2011) MicroRNAs as biomarkers of disease onset. Anal Bioanal Chem 401:2051\u20132061","journal-title":"Anal Bioanal Chem"},{"key":"1549_CR12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/path.2806","volume":"223","author":"TA Farazi","year":"2011","unstructured":"Farazi TA, Spitzer JI, Morozov P, Tuschl T (2011) miRNAs in human cancer. J Pathol 223:102\u2013115","journal-title":"J Pathol"},{"key":"1549_CR13","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.seminoncol.2011.08.001","volume":"38","author":"C Braconi","year":"2011","unstructured":"Braconi C, Henry JC, Kogure T, Schmittgen T, Patel T (2011) The role of microRNAs in human liver cancers. Semin Oncol 38:752\u2013763","journal-title":"Semin Oncol"},{"key":"1549_CR14","doi-asserted-by":"crossref","first-page":"20471","DOI":"10.1073\/pnas.1009009107","volume":"107","author":"S Cairo","year":"2010","unstructured":"Cairo S, Wang Y, de Reynies A, Duroure K, Dahan J, Redon MJ, Fabre M, McClelland M, Wang XW, Croce CM, Buendia MA (2010) Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci U S A 107:20471\u201320476","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1549_CR15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.trsl.2011.01.008","volume":"157","author":"TA Kerr","year":"2011","unstructured":"Kerr TA, Korenblat KM, Davidson NO (2011) MicroRNAs and liver disease. Transl Res 157:241\u2013252","journal-title":"Transl Res"},{"key":"1549_CR16","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3748\/wjg.v17.i20.2536","volume":"17","author":"AM Lakner","year":"2011","unstructured":"Lakner AM, Bonkovsky HL, Schrum LW (2011) microRNAs: fad or future of liver disease. World J Gastroenterol 17:2536\u20132542","journal-title":"World J Gastroenterol"},{"key":"1549_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2407-13-21","volume":"13","author":"M Rong","year":"2013","unstructured":"Rong M, Chen G, Dang Y (2013) Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. BMC Cancer 13:21","journal-title":"BMC Cancer"},{"key":"1549_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1593\/tlo.09124","volume":"2","author":"A Magrelli","year":"2009","unstructured":"Magrelli A, Azzalin G, Salvatore M, Viganotti M, Tosto F, Colombo T, Devito R, Di Masi A, Antoccia A, Lorenzetti S, Maranghi F, Mantovani A, Tanzarella C, Macino G, Taruscio D (2009) Altered microRNA expression patterns in hepatoblastoma patients. Transl Oncol 2:157\u2013163","journal-title":"Transl Oncol"},{"key":"1549_CR19","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/1097-0142(20011215)92:12<3130::AID-CNCR10115>3.0.CO;2-#","volume":"92","author":"JE Haas","year":"2001","unstructured":"Haas JE, Feusner JH, Finegold MJ (2001) Small cell undifferentiated histology in hepatoblastoma may be unfavorable. Cancer 92:3130\u20133134","journal-title":"Cancer"},{"key":"1549_CR20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/pbc.24217","volume":"59","author":"G Perilongo","year":"2012","unstructured":"Perilongo G, Malogolowkin M, Feusner J (2012) Hepatoblastoma clinical research: lessons learned and future challenges. Pediatr Blood Cancer 59:818\u2013821","journal-title":"Pediatr Blood Cancer"},{"key":"1549_CR21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","volume":"40","author":"G Perilongo","year":"2004","unstructured":"Perilongo G, Shafford E, Maibach R, Aronson D, Brugieres L, Brock P, Childs M, Czauderna P, MacKinlay G, Otte JB, Pritchard J, Rondelli R, Scopinaro M, Staalman C, Plaschkes J (2004) Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the international society of paediatric oncology\u2014SIOPEL 2. Eur J Cancer 40:411\u2013421","journal-title":"Eur J Cancer"},{"key":"1549_CR22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2353\/jmoldx.2008.070153","volume":"10","author":"M Doleshal","year":"2008","unstructured":"Doleshal M, Magotra AA, Choudhury B, Cannon BD, Labourier E, Szafranska AE (2008) Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues. J Mol Diagn 10:203\u2013211","journal-title":"J Mol Diagn"},{"key":"1549_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mc.21864","volume":"52","author":"A Karakatsanis","year":"2013","unstructured":"Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D (2013) Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 52:297\u2013303","journal-title":"Mol Carcinog"},{"key":"1549_CR24","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/hep.22158","volume":"47","author":"H Varnholt","year":"2008","unstructured":"Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M (2008) MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47:1223\u20131232","journal-title":"Hepatology"},{"key":"1549_CR25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.0907904107","volume":"107","author":"P Pineau","year":"2010","unstructured":"Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A (2010) miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 107:264\u2013269","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1549_CR26","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","volume":"64","author":"CL Andersen","year":"2004","unstructured":"Andersen CL, Jensen JL, Orntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245\u20135250","journal-title":"Cancer Res"},{"key":"1549_CR27","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jpedsurg.2011.11.073","volume":"47","author":"H Ismail","year":"2012","unstructured":"Ismail H, Broniszczak D, Kalicinski P, Dembowska-Baginska B, Perek D, Teisseyre J, Kluge P, Kosciesza A, Lembas A, Markiewicz M (2012) Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20\u00a0years. J Pediatr Surg 47:1331\u20131339","journal-title":"J Pediatr Surg"},{"key":"1549_CR28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10555-009-9188-5","volume":"28","author":"SK Shenouda","year":"2009","unstructured":"Shenouda SK, Alahari SK (2009) MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28:369\u2013378","journal-title":"Cancer Metastasis Rev"},{"key":"1549_CR29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","volume":"40","author":"D Lopez-Terrada","year":"2009","unstructured":"Lopez-Terrada D, Gunaratne PH, Adesina AM, Pulliam J, Hoang DM, Nguyen Y, Mistretta TA, Margolin J, Finegold MJ (2009) Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK + precursors. Hum Pathol 40:783\u2013794","journal-title":"Hum Pathol"},{"key":"1549_CR30","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00383-010-2699-x","volume":"26","author":"A Chopra","year":"2010","unstructured":"Chopra A, Iyer VK, Agarwala S, Mathur SR, Aron M, Gupta SD, Verma K (2010) Apoptotic protein expression, glycogen content, DNA ploidy and cell proliferation in hepatoblastoma subtyping and their role in prognostication. Pediatr Surg Int 26:1173\u20131178","journal-title":"Pediatr Surg Int"},{"key":"1549_CR31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.24125","volume":"53","author":"J Frowein von","year":"2011","unstructured":"von Frowein J, Pagel P, Kappler R, von Schweinitz D, Roscher A, Schmid I (2011) MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. Hepatology 53:833\u2013842","journal-title":"Hepatology"},{"key":"1549_CR32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2011.11.017","volume":"56","author":"C Scisciani","year":"2012","unstructured":"Scisciani C, Vossio S, Guerrieri F, Schinzari V, De Iaco R, D\u2019Onorio de Meo P, Cervello M, Montalto G, Pollicino T, Raimondo G, Levrero M, Pediconi N (2012) Transcriptional regulation of miR-224 upregulated in human HCCs by NFkappaB inflammatory pathways. J Hepatol 56:855\u2013861","journal-title":"J Hepatol"},{"key":"1549_CR33","doi-asserted-by":"crossref","first-page":"18066","DOI":"10.1074\/jbc.M110.196451","volume":"286","author":"DR Boutz","year":"2011","unstructured":"Boutz DR, Collins PJ, Suresh U, Lu M, Ramirez CM, Fernandez-Hernando C, Huang Y, Abreu Rde S, Le SY, Shapiro BA, Liu AM, Luk JM, Aldred SF, Trinklein ND, Marcotte EM, Penalva LO (2011) Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. J Biol Chem 286:18066\u201318078","journal-title":"J Biol Chem"},{"key":"1549_CR34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s13238-012-2036-3","volume":"3","author":"J Hu","year":"2012","unstructured":"Hu J, Xu Y, Hao J, Wang S, Li C, Meng S (2012) MiR-122 in hepatic function and liver diseases. Protein Cell 3:364\u2013371","journal-title":"Protein Cell"},{"key":"1549_CR35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.22919","volume":"50","author":"T Xu","year":"2009","unstructured":"Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, Zhuang SM (2009) MicroRNA-195 suppresses tumorigenicity and regulates G1\/S transition of human hepatocellular carcinoma cells. Hepatology 50:113\u2013121","journal-title":"Hepatology"},{"key":"1549_CR36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/08941939.2011.618523","volume":"25","author":"L Chen","year":"2012","unstructured":"Chen L, Jiang M, Yuan W, Tang H (2012) miR-17-5p as a novel prognostic marker for hepatocellular carcinoma. J Invest Surg 25:156\u2013161","journal-title":"J Invest Surg"},{"key":"1549_CR37","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.yexcr.2012.02.010","volume":"318","author":"W Yang","year":"2012","unstructured":"Yang W, Sun T, Cao J, Liu F, Tian Y, Zhu W (2012) Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp Cell Res 318:944\u2013954","journal-title":"Exp Cell Res"},{"key":"1549_CR38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbrc.2013.04.003","volume":"434","author":"HM Tayebi El","year":"2013","unstructured":"El Tayebi HM, Omar K, Hegy S, El Maghrabi M, El Brolosy M, Hosny KA, Esmat G, Abdelaziz AI (2013) Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern. Biochem Biophys Res Commun 434:421\u2013427","journal-title":"Biochem Biophys Res Commun"},{"key":"1549_CR39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bbrc.2012.10.039","volume":"428","author":"X Wang","year":"2012","unstructured":"Wang X, Chen J, Li F, Lin Y, Zhang X, Lv Z, Jiang J (2012) MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of beta-catenin. Biochem Biophys Res Commun 428:525\u2013531","journal-title":"Biochem Biophys Res Commun"},{"key":"1549_CR40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/bjc.2012.587","volume":"108","author":"W Wu","year":"2013","unstructured":"Wu W, Takanashi M, Borjigin N, Ohno SI, Fujita K, Hoshino S, Osaka Y, Tsuchida A, Kuroda M (2013) MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis. Br J Cancer 108:653\u2013661","journal-title":"Br J Cancer"},{"key":"1549_CR41","doi-asserted-by":"crossref","first-page":"40142","DOI":"10.1074\/jbc.M111.251793","volume":"286","author":"M Brock","year":"2011","unstructured":"Brock M, Trenkmann M, Gay RE, Gay S, Speich R, Huber LC (2011) MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes. J Biol Chem 286:40142\u201340150","journal-title":"J Biol Chem"},{"key":"1549_CR42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1078-0432.CCR-09-1840","volume":"16","author":"QW Wong","year":"2010","unstructured":"Wong QW, Ching AK, Chan AW, Choy KW, To KF, Lai PB, Wong N (2010) MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin Cancer Res 16:867\u2013875","journal-title":"Clin Cancer Res"},{"key":"1549_CR43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/156652412798376170","volume":"12","author":"M Garofalo","year":"2012","unstructured":"Garofalo M, Quintavalle C, Romano G, Croce CM, Condorelli G (2012) miR221\/222 in cancer: their role in tumor progression and response to therapy. Curr Mol Med 12:27\u201333","journal-title":"Curr Mol Med"},{"key":"1549_CR44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3892\/ol.2012.742","volume":"4","author":"D Ma","year":"2012","unstructured":"Ma D, Tao X, Gao F, Fan C, Wu D (2012) miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling. Oncol Lett 4:483\u2013488","journal-title":"Oncol Lett"},{"key":"1549_CR45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1746-1596-8-69","volume":"8","author":"SN Shen","year":"2013","unstructured":"Shen SN, Wang LF, Jia YF, Hao YQ, Zhang L, Wang H (2013) Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagn Pathol 8:69","journal-title":"Diagn Pathol"},{"key":"1549_CR46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12094-012-0972-2","volume":"15","author":"S Lu","year":"2013","unstructured":"Lu S, Wang S, Geng S, Ma S, Liang Z, Jiao B (2013) Upregulation of microRNA-224 confers a poor prognosis in glioma patients. Clin Transl Oncol 15:569\u2013574","journal-title":"Clin Transl Oncol"},{"key":"1549_CR47","first-page":"1660","volume":"27","author":"Q Zhu","year":"2012","unstructured":"Zhu Q, Wang Z, Hu Y, Li J, Li X, Zhou L, Huang Y (2012) miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep 27:1660\u20131668","journal-title":"Oncol Rep"},{"key":"1549_CR48","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2013.05.007","volume":"337","author":"L Bao","year":"2013","unstructured":"Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Chen J, Su C (2013) MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT\/ERK pathways. Cancer Lett 337:226\u2013236","journal-title":"Cancer Lett"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1549-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-014-1549-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1549-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T23:20:21Z","timestamp":1565220021000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-014-1549-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,26]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1549"],"URL":"https:\/\/doi.org\/10.1007\/s00428-014-1549-y","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,26]]}}}